334 related articles for article (PubMed ID: 8479018)
21. [3 years' experience with intracavernous auto-injection therapy].
Weiske WH
Urologe A; 1989 Sep; 28(5):253-6. PubMed ID: 2815435
[TBL] [Abstract][Full Text] [Related]
22. [Intracavernous pharmacotherapy for organic impotence in the elderly].
Richter S; Shalev M; Nissenkorn I
Harefuah; 1990 Aug; 119(3-4):66-7. PubMed ID: 2227669
[TBL] [Abstract][Full Text] [Related]
23. [Percutaneous use of vasoactive drugs in the diagnosis and treatment of erectile impotence].
Pastorini S; Marino G; Cocimano V; Marten Perolino R
Minerva Urol Nefrol; 1992; 44(3):191-3. PubMed ID: 1492270
[TBL] [Abstract][Full Text] [Related]
24. Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction.
Montorsi F; Guazzoni G; Bergamaschi F; Ferini-Strambi L; Barbieri L; Rigatti P
J Urol; 1993 May; 149(5 Pt 2):1291-5. PubMed ID: 7683061
[TBL] [Abstract][Full Text] [Related]
25. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
Engel JD; McVary KT
Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
[TBL] [Abstract][Full Text] [Related]
26. Intracavernous injections: still the gold standard for treatment of erectile dysfunction in elderly men.
Richter S; Vardi Y; Ringel A; Shalev M; Nissenkorn I
Int J Impot Res; 2001 Jun; 13(3):172-5. PubMed ID: 11525316
[TBL] [Abstract][Full Text] [Related]
27. Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
Stief CG; Wetterauer U; Kulvelis F; Popken G; Staubesand J; Sommerkamp H
Urol Int; 1990; 45(6):321-5. PubMed ID: 2288047
[TBL] [Abstract][Full Text] [Related]
28. Erectile responses to intracavernous papaverine and phentolamine: comparison of single and combined delivery.
Stief CG; Wetterauer U
J Urol; 1988 Dec; 140(6):1415-6. PubMed ID: 3193506
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence.
Montorsi F; Guazzoni G; Bergamaschi F; Dodesini A; Rigatti P; Pizzini G; Miani A
Urology; 1993 Nov; 42(5):554-8. PubMed ID: 7694416
[TBL] [Abstract][Full Text] [Related]
30. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
Chandeck Montesa K; Chen Jiménez J; Tamayo JC; Rodríguez Antolín A; Alvarez González E
Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients.
Stief CG; Wetterauer U; Schaebsdau FH; Jonas U
J Urol; 1991 Oct; 146(4):1010-4. PubMed ID: 1895414
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic erection program for the treatment of male impotence.
Trapp JD
South Med J; 1987 Apr; 80(4):426-7. PubMed ID: 2436316
[TBL] [Abstract][Full Text] [Related]
33. Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.
Allen RP; Engel RM; Smolev JK; Brendler CB
J Urol; 1992 Oct; 148(4):1181-3. PubMed ID: 1404632
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
[TBL] [Abstract][Full Text] [Related]
35. [Corpus cavernosum injection treatment of erectile impotence].
Lenk S; Schönherr G; Korner I
Z Urol Nephrol; 1990 Oct; 83(10):539-46. PubMed ID: 2095661
[TBL] [Abstract][Full Text] [Related]
36. Intracavernous injections for impotence.
Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
[No Abstract] [Full Text] [Related]
37. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
Sidi AA; Cameron JS; Duffy LM; Lange PH
J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive intracavernous pharmacotherapy.
Sidi AA
Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756
[TBL] [Abstract][Full Text] [Related]
39. Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence.
Kattan S; Collins JP; Mohr D
Urology; 1991 Jun; 37(6):516-8. PubMed ID: 2038782
[TBL] [Abstract][Full Text] [Related]
40. Impotence: treatment by autoinjection of vasoactive drugs.
Williams G; Mulcahy MJ; Kiely EA
Br Med J (Clin Res Ed); 1987 Sep; 295(6598):595-6. PubMed ID: 3117249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
